Olema Pharmaceuticals
OLMA
OLMA
87 hedge funds and large institutions have $329M invested in Olema Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
7.09% more ownership
Funds ownership: 82.24% → 89.34% (+7.1%)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
Holders
87
Holding in Top 10
2
Calls
$370K
Puts
$278K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$12.2M | |
| 3 | +$12.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.31M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$4.18M |
Top Sellers
| 1 | -$7.28M | |
| 2 | -$6.39M | |
| 3 | -$5.36M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$3.16M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.14M |